Disruption of the Shc/Grb2 complex during Abelson virus transformation affects proliferation, but not apoptosis

Journal of Virology

Volumn 79, Issue 4, 2005, Pages 2325-2334

  Baughn, Linda B ^a   Rosenberg, Naomi ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SHC; RAC PROTEIN; RAF PROTEIN; RAS PROTEIN;

ABELSON MURINE LEUKEMIA ONCOVIRUS; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; FLOW CYTOMETRY; IMMUNOPRECIPITATION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; VIRUS TRANSFORMATION; WESTERN BLOTTING;

ABELSON MURINE LEUKEMIA VIRUS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION, VIRAL; GENE EXPRESSION REGULATION, VIRAL; GRB2 ADAPTOR PROTEIN; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; RAS PROTEINS; SIGNAL TRANSDUCTION;

ABELSON MURINE LEUKEMIA VIRUS; ABELSON VIRUS; MURINAE; MURINE LEUKEMIA ONCOVIRUS; MURINE LEUKEMIA VIRUS; ONCOVIRINAE; RNA VIRUSES;

EID: 13444253830     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.4.2325-2334.2005     Document Type: Article

References (67)

1. Afar, D. E. H., A. Goga, J. McLaughlin, O. N. Witte, and C. L. Sawyers. 1994. Differential complementation of Bcr-Abl point mutants with c-Myc. Science 264:424-426.
2. Alavi, A., J. D. Hood, R. Frausto, D. G. Slupack, and D. A. Cheresh. 2003. Role of Raf in vascular protection from distinct apoptotic stimuli. Science 301:94-96.
3. Bagrodia, S., S. J. Taylor, C. L. Creasy, J. Chernoff, and R. A. Cerione. 1995. Identification of a mouse p21Cdc42/Rac activated kinase. J. Biol. Chem. 270:22731-22737.
4. Campell, K. S., E. Orgis, B. Burke, W. Su, K. R. Auger, B. J. Druker, B. S. Schaffhausen, T. M. Roberts, and D. C. Pallas. 1994. Polyoma middle tumor antigen interacts with She protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. Proc. Natl. Acad. Sci. USA 91:6344-6348.
5. Campell, S. L., R. Khosravi-Far, K. L. Rossman, G. J. Clark, and C. J. Der. 1998. Increasing complexity of Ras signaling. Oncogene 17:1395-1413.
6. Carpino, N., D. Wisniewski, A. Strife, D. Marshak, R. Kobayashi, B. Stillman, and B. Clarkson. 1997. p62(dok): a constitutively tyrosine- phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 88:197-204.
7. Chaudhary, A., W. G. King, M. D. Mattalian, J. A. Frost, B. Diaz, D. K. Morrison, M. H. Cobb, M. S. Marshall, and J. S. Brugge. 2000. Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338. Curr. Biol. 10:551-554.
8. 1. Proc. Natl. Acad. Sci. USA 89:6683-6687.
9. Chesebro, B., K. Wehrly, M. Cloyd, W. Britt, J. Portis, J. Collins, and J. Nishio. 1981. Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens. Virology 112:131-144.
10. Cortez, D., L. Kadlec, and A. M. Pendergast. 1995. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis. Mol. Cell. Biol. 15:5531-5541.
11. 1-to-S phase transition in hematopoietic cells. Oncogene 15:2333-2342.
12. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92:7686-7689.
13. Egan, S. E., B. W. Giddings, M. W. Brooks, L. Buday, A. M. Sizeland, and R. A. Weinberg. 1993. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature (London) 363:45-51.
14. Fabian, J. R., I. O. Daar, and D. K. Morrison. 1993. Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase. Mol. Cell. Biol. 13:7170-7179.
15. Glaven, J. A., I. Whitehead, S. Bagrodia, R. Kay, and R. A. Cerione. 1999. The Dbl-related protein, Lfc, localizes to microtubules and mediates the activation of Rac signaling pathways in cells. J. Biol. Chem. 274:2279-2285.
16. Goga, A., J. McLaughlin, D. E. H. Afar, D. C. Saffran, and O. N. Witte. 1995. Alternative signals to Ras for hematopoietic transformation by the Bcr-Abl oncogene. Cell 82:981-988.
17. Gong, L., I. Unnikrishnan, A. Raghavan, K. Parmar, and N. Rosenberg. 2004. Active Akt and functional p53 modulate apoptosis in Abelson virus-transformed pre-B cells. J. Virol. 78:1636-1644.
18. Gotoh, N., A. Tojo, and M. Shibuya. 1996. A novel pathway from phosphorylation of tyrosine residues 239/240 of Shc, contributing to suppress apoptosis by IL-3. EMBO J. 15:6197-6204.
19. Gu, H., H. Maeda, J. J. Moon, J. D. Lord, M. Yoakim, B. H. Nelson, and B. G. Neel. 2000. New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway. Mol. Cell. Biol. 20:7109-7120.
20. Harmer, S. L., and A. L. DeFranco. 1997. Shc contains two Grb2 binding sites needed for efficient formation of complexes with SOS in lymphocytes. Mol. Cell. Biochem. 17:4087-4095.
21. Hawley, R. G., F. H. Lieu, A. Z. Fong, and T. S. Hawley. 1994. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1:136-138.
22. ras and the Ras-binding domain of the human Raf-1 protein kinase. J. Biol. Chem. 270:2901-2905.
23. Khosravi-Far, R., S. Campbell, K. L. Rossman, and C. J. Der. 1998. Increasing complexity of Ras signal transduction: involvement of Rho family proteins. Adv. Cancer Res. 72:57-107.
24. Lord, J. D., B. C. McIntosh, P. D. Greenberg, and B. H. Nelson. 1998. The IL-2 receptor promotes proliferation, bcl-2 and bcl-x induction, but not cell viability through the adapter molecule Shc. J. Immunol. 161:4627-4633.
25. Lowenstein, E. J., R. J. Daly, A. G. Batzer, W. Li, B. Margolis, R. Lammers, A. Ullrich, E. V. Skolink, D. Bar-Sagi, and J. Schlessinger. 1992. The SH2 and SH3 domain-containing protein Grb2 links receptor tyrosine kinases to ras signaling. Cell 70:431-442.
26. Mainville, C., K. Parmar, I. Unnikrishnan, G. D. Raffel, L. Gong, and N. Rosenberg. 2001. Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain. J. Virol. 75:1816-1823.
27. Majewski, M., M. Nieborowska-Skorska, P. Salomoni, A. Slupianek, K. Reiss, R. Trotta, B. Calabretta, and T. Skorski. 1999. Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt. Cancer Res. 59:2815-2819.
28. Marais, R., Y. Light, H. F. Paterson, and C. J. Marshall. 1995. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 14:3136-3145.
29. Mason, C. S., C. J. Springer, R. G. Cooper, G. Superti-Furga, C. J. Marshall, and R. Marais. 1999. Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation. EMBO J. 18:2137-2148.
30. Mayer, B. J., P. K. Jackson, R. A. Van Etten, and D. Baltimore. 1992. Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo. Mol. Cell. Biol. 12:609-618.
31. Mercalli, E., S. Ghizzoni, E. Arighi, L. Alberti, S. R., M. T. Radice, M. L. Gishizky, M. A. Pierotti, and M. G. Borrello. 2001. Key role of Shc signaling in the transforming pathway triggered by Ret/ptc2 oncoprotein. Oncogene 20:3475-3485.
32. 1 phase of the cell cycle. Mol. Cell 8:115-127.
33. Muljo, S. A., and M. S. Schlissel. 2003. A small molecular Abl kinase inhibitor induces differentiation of Abelson-virus-transformed pre-B cell lines. Nat. Immunol. 4:31-37.
34. Neshat, M. S., A. B. Raitano, H. G. Wang, J. C. Reed, and C. L. Sawyers. 2000. The survival function of the Bcr-Abl oncogene is mediated by Bad-dependent and -independent pathways: roles for phosphatidylinositol 3-kinase and Raf. Mol. Cell. Biol. 20:1179-1186.
35. Owen-Lynch, P. J., A. K. Wong, and A. D. Whetton. 1995. v-Abl-mediated apoptotic suppression is associated with SHC phosphorylation without concomitant mitogen-activated protein kinase activation. J. Biol. Chem. 270:5956-5962.
36. Pelicci, G., L. Lanfrancone, F. Grignani, J. McGlade, F. Cavallo, G. Forni, I. Nicoletti, F. Grignani, T. Pawson, and P. G. Pelicci. 1992. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70:93-104.
37. Pelicci, G., L. Lanfrancone, A. E. Salcini, A. Romano, G. Mele, M. Grazia Borrello, O. Segatto, P. P. Di Fiore, and P. G. Pelicci. 1995. Constitutive phosphorylation of Shc proteins in human tumors. Oncogene 11:899-907.
38. Raffel, G. D., K. Parmar, and N. Rosenberg. 1996. In vivo association of v-Abl with Shc mediated by a non-phosphotyrosine-dependent SH2 interaction. J. Biol. Chem. 271:4640-4645.
39. Raitano, A. B., J. R. Halpern, T. M. Hambuch, and C. L. Sawyers. 1995. The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation. Proc. Natl. Acad. Sci. USA 92:11746-11750.
40. Ravichandran, K. S. 2001. Signaling via Shc family adapter proteins. Oncogene 20:6322-6330.
41. Ren, R., Z.-S. Ye, and D. Baltimore. 1994. Abl protein-tyrosine kinase selects the crk adapter as a substrate using SH3-binding sites. Genes Dev. 8:783-795.
42. Renshaw, M. W., E. Lea-Chou, and J. Y. J. Wang. 1996. Rac is required for v-Abl tyrosine kinase to activate mitogenesis. Curr. Biol. 6:76-83.
43. Rosenberg, N., and O. N. Witte. 1988. The viral and cellular forms of the Abelson (abl) oncogene. Adv. Virus Res. 35:39-81.
44. Rozakis-Adcock, M., J. McGlade, G. Mbamulu, G. Pelicci, R. J. Daly, W. Li, A. G. Batzer, S. Thomas, J. Brugge, P. G. Pelicci, J. Schlessinger, and T. Pawson. 1993. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature (London) 260:689-692.
45. Salcini, A. E., J. McGlade, G. Pelicci, I. Nicoletti, T. Pawson, and P. G. Pelicci. 1994. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene 9:2827-2836.
46. Sattler, M., M. G. Mohi, Y. B. Pride, L. R. Quinnan, N. A. Malouf, K. Podar, F. Gesbert, H. Iwasaki, S. Li, R. A. Van Etten, H. Gu, J. D. Griffin, and B. G. Neel. 2002. Critical role for Gab2 in transformation by BCR/ABL. Cancer Cell 1:479-492.
47. Sawyers, C. L., W. Callahan, and O. N. Witte. 1992. Dominant negative myc blocks transformation by abl oncogenes. Cell 70:901-910.
48. Sawyers, C. L., J. McLaughlin, and O. N. Witte. 1995. Genetic requirement for ras in the transformation of fibroblasts and hematopoietic cells by the bcr-abl oncogene. J. Exp. Med. 181:307-313.
49. Schiff-Maker, L., M. C. Burns, J. B. Konopka, S. Clark, O. N. Witte, and N. Rosenberg. 1986. Monoclonal antibodies specific for v-abl- and c-abl-encoded molecules. J. Virol. 57:1182-1186.
50. Simon, A. R., H. G. Vikis, S. Stewart, B. L. Fanburg, B. H. Cochran, and K. L. Guan. 2000. Regulation of STAT3 by direct binding to the Rac1 GTPase. Science 290:144-147.
51. Sini, P., A. Cannas, A. J. Koleske, P. P. Di Fiore, and G. Scita. 2004. Abl-dependent tyrosine phosphorylation of Sos-1 mediates growth-factor-induced Rac activation. Nat. Cell Biol. 6:268-274.
52. Skorski, T., A. Bellacosa, M. Nieborowska-Skorska, M. Majewski, R. Martinez, J. K. Choi, R. Trotta, P. Wlodarski, D. Perrotti, T. O. Chan, M. A. Wasik, P. N. Tsichlis, and B. Calabretta. 1997. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3K/Akt-dependent pathway. EMBO J. 16:6151-6161.
53. Stevenson, L. E., and A. R. Frackelton. 1998. Constitutively tyrosine phosphorylated p52 Shc in breast cancer cells: correlation with ErbB2 and p66 Shc expression. Breast Cancer Res. Treat. 49:119-128.
54. 2-M of ErbB2-positive breast cancer cells. Cell Growth Diff. 10:61-71.
55. Tang, X., C. P. Downes, A. D. Whetton, and P. J. Owen-Lych. 2000. Role of phosphatidylinositol 3-kinase and specific protein kinase B isoforms in the suppression of apoptosis mediated by the Abelson protein-tyrosine kinase. J. Biol. Chem. 275:13142-13148.
56. Taylor, S. J., and D. Shalloway. 1996. Cell cycle-dependent activation of Ras. Curr. Biol. 6:1621-1627.
57. Tran, N. H., and J. A. Frost. 2003. Phosphorylation of Raf-1 by p21-activated kinase 1 and Src regulates Raf-1 autoinhibition. J. Biol. Chem. 278:11221-11226.
58. Troppmair, J., J. T. Bruder, H. Munoz, P. A. Lloyd, J. Kyriakis, P. Banerjee, J. Avruch, and U. R. Rapp. 1994. Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation. J. Biol. Chem. 269:7030-7035.
59. van der Geer, P., S. Wiley, G. D. Gish, and T. Pawson. 1996. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions. Curr. Biol. 6:1435-1444.
60. Van Parijs, L., Y. Refaeli, J. D. Lord, B. H. Nelson, A. K. Abbas, and D. Baltimore. 1999. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation induced cell death. Immunity 11:281
61. Walk, S. F., M. E. March, and K. S. Ravichandran. 1998. Roles of Lck, Syk and Zap-70 tyrosine kinases in TCR-mediated phosphorylation of the adapter protein Shc. Eur. J. Immunol. 8:2265-2275.
62. Warren, D., D. Griffin, C. A. Mainville, and N. Rosenberg. 2003. The extreme carboxyl terminus of v-Abl protein is required for lymphoid transformation by Abelson virus. J. Virol. 77:4617-4625.
63. Warren, D., A. J. Heilpern, K. Berg, and N. Rosenberg. 2000. The carboxyl terminus of v-Abl protein can augment SH2 domain function. J. Virol. 74:4495-4504.
64. Weissinger, E. M., G. Eissner, C. Grammer, A. Fackler, B. Haefner, L. S. Yoon, K. S. Lu, A. Bazarov, J. M. Sedivy, H. Mischak, and W. Kolch. 1997. Inhibition of the Raf-1 kinase by cyclin AMP agonists causes apoptosis of v-abl-transformed cells. Mol. Cell. Biol. 17:3229-3241.
65. Yamanashi, Y., and D. Baltimore. 1997. Identification of the Abl- and ras-GAP-associated 62 kDa protein as a docking protein, Dok. Cell 88:205-211.
66. Zou, X., and K. Calame. 1999. Signaling pathways activated by oncogenic forms of Abl tyrosine kinase. J. Biol. Chem. 274:18141-18144.
67. Zou, X., S. Rudchenko, K.-K. Wong, and K. Calame. 1997. Induction of c-myc transcription by the v-Abl tyrosine kinase requires Ras, Raf1, and cyclin-dependent kinases. Genes Dev. 11:654-662.